Stay updated with breaking news from Stemcells Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Business Research Company covers the macular dege neration treatment market drivers and restraints, market size and the impact of COVID-19 on the market.
Microbot Medical (NASDAQ:MBOT – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product […]
Equities Research Analysts’ upgrades for Friday, April 22nd: American Airlines Group (NASDAQ:AAL) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. They currently have $26.00 price target on the stock, up from their previous price target of $18.00. American Airlines Group (NASDAQ:AAL) was upgraded by analysts at […]
Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Global Market Report 2022, By Source, By Product Type, By Application" report has been added to...
Zacks Investment Research upgraded shares of Microbot Medical (NASDAQ:MBOT – Get Rating) from a sell rating to a hold rating in a report published on Thursday morning, Zacks.com reports. According to Zacks, “Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self […]